The Journal of Medical Sciences

Register      Login

VOLUME 9 , ISSUE 1 ( January-December, 2023 ) > List of Articles

Original Article

Cross-sectional and Prospective Study of Aerobic Vaginitis and Its Outcomes in Pregnant Women Attending a Rural Teaching Hospital, Telangana

Kalpana Basany, Meera Rajgopal, Mahathi Nadella, Kiranmai Sannithi

Keywords : Aerobic vaginitis scoring, Follow-up, Pregnancy outcomes, Vaginitis

DOI: 10.5005/jp-journals-10045-00234

License: CC BY-NC 4.0

Published Online: 19-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Aims and background: Aerobic vaginitis (AV) is an alteration in vaginal bacterial flora. AV has drawn attention because of its threat to women's reproductive health and pregnancy. If AV is not diagnosed early and treated correctly, it can diffuse in the genital apparatus and during pregnancy can cause abnormal outcomes like preterm birth, premature rupture of membrane (PROM) chorioamnionitis, etc. Little is known about the treatment's success in reducing adverse pregnancy outcomes in mothers with AV infection. The study aims to report the prevalence of AV in pregnant women and to provide evidence of the threat of AV on pregnancy outcomes. Materials and methods: Vaginal swab specimens were obtained from females attending the obstetric outpatient department (OPD) from June 2021 to May 2022. Swab samples were immediately sent to the laboratory for Gram stain, AV scoring, and culture and sensitivity. All participants were followed up to evaluate pregnancy outcomes. Results: A total of 197 pregnant women enrolled in the study, 21 (10.7%) women were having AV. The majority of the isolates belong to the Staphylococcus species (47.9%, 11/23) followed by Escherichia coli (E. coli) (26.1%, 6/23). Antibiotic resistance has shown to be minimal. Conclusion: Screening of all pregnant women for infections like AV contributes to the improvement of pregnancy outcomes. Clinical significance: Knowing the incidence of the infection and its outcomes improves the standard of care among pregnant women.

PDF Share
  1. Donders GG, Vereecken A, Bosmans E, et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002;109(1):34–43. DOI: 10.1111/j.1471-0528.2002.00432.x
  2. Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG 2011;118(10):1163–1170. DOI: 10.1111/j.1471-0528.2011.03020.x
  3. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 2009;116(10):1315–1324. DOI: 10.1111/j.1471-0528.2009.02237.x
  4. Rabiee S, Arab M, Yousefi MR. Epidemiologic pattern of vaginal colonization by group B Streptococcus in pregnant women in Hamadan, Central West of Iran. Iran J Med Sci 2006;31(2):106–108.
  5. Najmi N, Jehan I, Sikandar R, et al. Maternal genital tract colonization by group-B Streptococcus: a hospital based study. J Pak Med Assoc 2013;63(9):1103–1107.
  6. Hemalatha R, Ramalaxmi BA, KrishnaSwetha G, et al. Cervicovaginal inflammatory cytokines and sphingomyelinase in women with and without bacterial vaginosis. Am J Med Sci 2012;344(1):35–39. DOI: 10.1097/MAJ.0b013e318235597b
  7. MacPhee RA, Miller WL, Gloor GB, et al. Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol 2013;79(6):1835–1842. DOI: 10.1128/AEM.02908-12
  8. Tansarli GS, Kostaras EK, Anthanasiou S, et al. Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis 2013;32(8):977–984. DOI: 10.1007/s10096-013-1846-4
  9. Donati L, Di Vico A, Nucci M, Quagliozzi L, et al. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet 2010;281(4):589–600. DOI: 10.1007/s00404-009-1318-3
  10. Wang S, Hibberd ML, Pettersson S, et al. Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways. PLoS One 2014;9(5):e97523. DOI: 10.1371/journal.pone.0097523
  11. Donders GG. Definition and classification of abnormal vaginal flora. Best Pract Clin Obstet Gynaecol 2007;21(3):355–373. DOI: 10.1016/j.bpobgyn.2007.01.002
  12. Zarbo G, Coco L, Leanza V, et al. Aerobic vaginitis during pregnancy. Res Obstet Gynecol 2013;2(2):7–11. DOI: 10.5923/j.rog.20130202.01
  13. Akerele J, Abhulimen P, Okonofua F. Prevalence of asymptomatic genital infection among pregnant women in Benin City, Nigeria. Afr J Reprod Health 2002;6(3):93–97. DOI: 10.2307/3583261
  14. Stojanovic N, Plecas D, Plesinac S. Normal vaginal flora, disorders and application of probiotics in pregnancy. Arch Gynecol Obstet 2012;286(2):325–332. DOI: 10.1007/s00404-012-2293-7
  15. Honda H, Yokoyama T, Akimoto Y, et al. The frequent shift to intermediate flora in preterm delivery cases after abnormal vaginal flora screening. Sci Rep 2014;4:4799. DOI: 10.1038/srep04799
  16. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342(20):1500–1507. DOI: 10.1056/NEJM200005183422007
  17. Heczko PB, Tomusiak A, Adamski P, et al. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, doubleblind, placebo-controlled trial. BMC Womens Health 2015;15:115. DOI: 10.1186/s12905-015-0246-6
  18. Tomusiak A, Strus M, Heczko PB, et al. Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial. Drug Des Devel Ther 2015;9:5345–5354. DOI: 10.2147/DDDT.S89214
  19. Russo R, Edu A, De Seta F. Study on the effects of an oral lactobacilli and lactoferrin complex in women with intermediate vaginal microbiota. Arch Gynecol Obstet 2018;298(1):139–145. DOI: 10.1007/s00404-018-4771-z
  20. Han C, Wu W, Fan A, et al. Diagnostic and therapeutic advancements for aerobic vaginitis. Arch Gynecol Obstet 2015;291(2):251–257. DOI: 10.1007/s00404-014-3525-9
  21. Mackie TJ, McCartney JE. Laboratory strategy in the diagnosis of infective syndromes. In: Collee JG, Fraser AG, Marmion BP, Simmons A, (Eds). Practical Medical Microbiology, 14th edition. Edinburg: Churchill Livingstone; 2006. p. 796.
  22. Forbes BA, Daniel FS, Alice SW. Baily and Scott's Diagnostic Microbiology, 12th edition. USA: Mosby Elsevier Company; 2007. p. 867.
  23. Allen SD, Janda WM, Koneman EW, et al. Koneman's Color Atlas and Textbook of Diagnostic Microbiology, 6th edition. Philadelphia: Lippincott; 2005. pp. 1443–1535.
  24. CLSI - Clinical and Laboratory Standards Institute 2013. Performance standards for antimicrobial susceptibility testing. Twenty-third informational supplement. Wayne, PA, USA: CLSI; 2013. pp. M100-S23.
  25. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360(9344):1489–1497. DOI: 10.1016/S0140-6736(02)11476-0
  26. Blencowe H, Cousens S, Jassir FB, et al. National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health 2016;4(2):e98–e108. DOI: 10.1016/S2214-109X(15)00275-2
  27. World Health Organization. International statistical classification of diseases and related health problems, 10th revision, Fifth edition, 2016. World Health Organization. 2015.
  28. Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 188: prelabor rupture of membranes. Obstet Gynecol 2018;131(1):e1–e14. DOI: 10.1097/AOG.0000000000002455
  29. Chen ZL, Liu J. Interpretation of the experts’ consensus on the criteria for the diagnosis and grading of neonatal asphyxia in China. Transl Pediatr 2013;2(2):59–63. DOI: 10.3978/j.issn.2224-4336.2013.04.02
  30. Zodzika J, Jermakowa I, Rezeberga D, et al. Factors related to elelvated vaginal pH in the first trimester of pregnancy. Acta Obstet Gynecol Scand 2011;90(1):41–46. DOI: 10.1111/j.1600-0412.2010.01011.x
  31. Sangeetha KT, SarojGolia, Vasudha CL. A study of aerobic bacterial pathogens associated with vaginitis in reproductive age group women (15-45 years) and their sensitivity pattern. Int J Res Med Sci 2015;3(9):2268–2273. DOI: 10.18203/2320-6012.ijrms20150615
  32. Tang Y, Yu F, Hu Z, et al. Characterization of aerobic vaginitis in late pregnancy in a Chinese population: a STROBE-compliant study. Medicine 2020;99(25):e20732. DOI: 10.1097/MD.0000000000020732
  33. Tempera G, Bonfiglio G, Cammarata E, et al. Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int J Antimicrob Agents 2004;24(1):85–88. DOI: 10.1016/j.ijantimicag.2003.12.013
  34. Fan A, Yue Y, Geng N, et al. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch Gynecol Obstet 2013;287(2):329–335. DOI: 10.1007/s00404-012-2571-4
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.